Humana Inc. Files 8-K Report

Ticker: HUM · Form: 8-K · Filed: 2025-06-02T00:00:00.000Z

Sentiment: neutral

Topics: regulation-fd, disclosure

Related Tickers: HUM

TL;DR

Humana filed an 8-K, likely for Reg FD. No major news yet.

AI Summary

On June 2, 2025, Humana Inc. filed an 8-K report to disclose information under Regulation FD. The filing does not detail specific transactions or events but serves as a notification of information being made available to the public.

Why It Matters

This filing indicates that Humana Inc. is making information public under Regulation FD, which ensures fair disclosure of material information to all investors.

Risk Assessment

Risk Level: low — The filing is a standard procedural disclosure under Regulation FD and does not contain information about specific material events or financial performance.

Key Players & Entities

FAQ

What is the purpose of this 8-K filing for Humana Inc.?

The purpose of this 8-K filing is to comply with Regulation FD disclosure requirements, indicating that Humana Inc. is making information available to the public.

What specific event or transaction is detailed in this 8-K filing?

This 8-K filing does not detail a specific event or transaction; it serves as a notification of information being disclosed under Regulation FD.

When was this 8-K report filed by Humana Inc.?

This 8-K report was filed on June 2, 2025.

What is Humana Inc.'s principal executive office address?

Humana Inc.'s principal executive office is located at 500 West Main Street, Louisville, Kentucky 40202.

Under which section of the Securities Exchange Act is this report filed?

This report is filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.

From the Filing

0000049071-25-000026.txt : 20250602 0000049071-25-000026.hdr.sgml : 20250602 20250602073012 ACCESSION NUMBER: 0000049071-25-000026 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20250602 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20250602 DATE AS OF CHANGE: 20250602 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANA INC CENTRAL INDEX KEY: 0000049071 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance EIN: 610647538 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05975 FILM NUMBER: 251013140 BUSINESS ADDRESS: STREET 1: 500 W MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 BUSINESS PHONE: 5025801000 MAIL ADDRESS: STREET 1: 500 W. MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 FORMER COMPANY: FORMER CONFORMED NAME: EXTENDICARE INC DATE OF NAME CHANGE: 19740404 FORMER COMPANY: FORMER CONFORMED NAME: HERITAGE HOUSE OF AMERICA INC DATE OF NAME CHANGE: 19671129 8-K 1 hum-20250602.htm 8-K hum-20250602 0000049071 false 0000049071 2025-06-02 2025-06-02 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2025 ( June 2, 2025 ) Humana Inc. (Exact name of registrant as specified in its charter) Delaware 001-5975 61-0647538 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 500 West Main Street , Louisville , Kentucky 40202 (Address of principal executive offices, including zip code) ( 502 ) 580-1000 (Registrant’s telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock HUM New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ Item 7.01. Regulation FD Disclosure. Members of Humana Inc.’s (the “Company”) senior management team are scheduled to meet with investors and analysts at various meetings between June 2, 2025 and June 30, 2025. During these meetings, the Company intends to reaffirm its guidance of approximately $14.68 in diluted earnings per common share (“EPS”) or approximately $16.25 in adjusted earnings per common share (“Adjusted EPS”), in each case for the year ending December 31, 2025 (“FY 2025”). This guidance is consistent with the guidance issued in the Company’s press release dated April 30, 2025. As a reminder, the Company will also host an Investor Conference for analysts and institutional investors on Monday, June 16, 2025, beginning at

View on Read The Filing